Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / IMMP - Immutep: A Small Company With A Pipeline Resembling Big Pharma

IMMP - Immutep: A Small Company With A Pipeline Resembling Big Pharma

Immutep Limited

2025-03-31 11:50:46 ET

Summary

  • Immutep's lead program, Eftilagimod Alpha, shows promising data in 1st line with NSCLC and HNSCC trials.
  • Despite positive trial results, IMMP's financials do not reflect its breadth of clinical programs.
  • The company has multiple ongoing programs, but prioritizing registrational trials and potential NDA submission in 2-3 years is crucial.
  • Due to the complex and overextended pipeline, I recommend staying away from IMMP until further regulatory progress is made.

...

For further details see:

Immutep: A Small Company With A Pipeline Resembling Big Pharma

Stock Information
Company Name: Immutep Limited
Stock Symbol: IMMP
Market: NASDAQ
Website: immutep.com
Menu
IMMP IMMP Quote IMMP Short IMMP News IMMP Articles IMMP Message Board
Get IMMP Alerts

News, Short Squeeze, Breakout and More Instantly...